Invus, L.P.
- SEC CIK
- 0001404570
No open-market purchases or sales filed in the past year.
Current role at each company
- LXRX Lexicon Pharmaceuticals, Inc.Director, 10% Owneras of May 14, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Invus, L.P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2023 (view filing)4:46 PM ET | Jun 5 | Same day | Artal Group S.A. and 9 othersDirector, 10% Owner | PPurchase | +27.8M | $2.60 | +$72.2M | +54.6%78.6M after | |
| Aug 9, 2022 (view filing)4:46 PM ET | Aug 5 | 4 days | Artal Group S.A. and 9 othersDirector, 10% Owner | PPurchase | +2.43M | $2.50 | +$6.07M | +5.0%50.9M after | |
| Aug 1, 2022 (view filing)4:15 PM ET | Aug 1 | Same day | Artal Group S.A. and 9 othersDirector, 10% Owner | PPurchase | +16.2M | $2.50 | +$40.4M | +50.1%48.4M after |